Total Payments
$585.26
2024 Payments
$13.50
Companies
9
Transactions
22
Medicare Patients
2,304
Medicare Billing
$334,581
Payment Breakdown by Category
Food & Beverage$585.26 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $585.26 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $161.90 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $136.64 | 8 | $0 (2023) |
| PFIZER INC. | $125.00 | 1 | $0 (2018) |
| Merck Sharp & Dohme LLC | $38.97 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $38.79 | 2 | $0 (2021) |
| ABBVIE INC. | $29.94 | 2 | $0 (2024) |
| Medtronic Vascular, Inc. | $21.17 | 1 | $0 (2018) |
| Medtronic, Inc. | $20.83 | 1 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $12.02 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.50 | 1 | ABBVIE INC. ($13.50) |
| 2023 | $77.18 | 5 | Janssen Pharmaceuticals, Inc ($60.74) |
| 2022 | $78.37 | 4 | Janssen Pharmaceuticals, Inc ($45.81) |
| 2021 | $66.00 | 4 | Medtronic, Inc. ($20.83) |
| 2019 | $67.02 | 4 | Janssen Pharmaceuticals, Inc ($30.09) |
| 2018 | $283.19 | 4 | E.R. Squibb & Sons, L.L.C. ($125.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Cardiovascular | ||||||
| 12/10/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/14/2021 | Medtronic, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Transcatheter Valve Systems | ||||||
| 07/13/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/14/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Cardiovascular | ||||||
| 12/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/17/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 05/10/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/15/2018 | Medtronic Vascular, Inc. | Compia MRI (Device) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiac Resynchronization Therapy - CRT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 527 | 838 | $272,875 | $67,607 |
| 2022 | 8 | 479 | 757 | $135,838 | $72,233 |
| 2021 | 11 | 668 | 1,112 | $189,607 | $106,206 |
| 2020 | 11 | 630 | 907 | $167,282 | $88,535 |
Total Patients
2,304
Total Services
3,614
Medicare Billing
$334,581
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 166 | 377 | $95,779 | $23,933 | 25.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 130 | 139 | $49,903 | $12,247 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 74 | $40,669 | $10,182 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 78 | $25,443 | $7,628 | 30.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 41 | $32,691 | $7,024 | 21.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 54 | 94 | $16,101 | $3,673 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $8,392 | $1,897 | 22.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $3,896 | $1,023 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 166 | 389 | $62,558 | $34,369 | 54.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 63 | $19,467 | $10,441 | 53.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 94 | 98 | $15,974 | $8,513 | 53.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $11,280 | $6,019 | 53.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 77 | $8,521 | $4,673 | 54.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 20 | $8,780 | $3,482 | 39.7% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 26 | 31 | $4,929 | $2,673 | 54.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 39 | 39 | $4,329 | $2,064 | 47.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 200 | 549 | $86,742 | $50,584 | 58.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 76 | 77 | $23,793 | $13,472 | 56.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 134 | 138 | $22,494 | $11,619 | 51.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 52 | 52 | $14,664 | $9,136 | 62.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 14 | 30 | $12,630 | $5,302 | 42.0% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 38 | 54 | $8,586 | $5,124 | 59.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 71 | $7,810 | $4,723 | 60.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 70 | 70 | $7,770 | $3,839 | 49.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 34 | $2,702 | $1,113 | 41.2% |
About Dr. Mohammed Guba, M.D
Dr. Mohammed Guba, M.D is a Internal Medicine healthcare provider based in Murphysboro, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1003292624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Guba, M.D has received a total of $585.26 in payments from pharmaceutical and medical device companies, with $13.50 received in 2024. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($585.26).
As a Medicare-enrolled provider, Guba has provided services to 2,304 Medicare beneficiaries, totaling 3,614 services with total Medicare billing of $334,581. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Hospitalist
- Location Murphysboro, IL
- Active Since 08/05/2015
- Last Updated 11/24/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003292624
Products in Payments
- ELIQUIS (Drug) $286.90
- XARELTO (Drug) $136.64
- ENTRESTO (Drug) $38.79
- DIFICID (Drug) $26.16
- Compia MRI (Device) $21.17
- CoreValve Evolut (Device) $20.83
- AVYCAZ (Drug) $16.44
- DALVANCE (Drug) $13.50
- ZERBAXA (Drug) $12.81
- LifeVest (Device) $12.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.